• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 362780
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/11/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that 30 bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml experienced hemolysis during use.The following information was provided by the initial reporter: cpt, isolated cells contaminated with erythrocytes and low vitality laboratory receives centrifuged cpt from participants of a clinical study; the cells collected above the gel are contaminated with erythrocytes, often the sample looks hemolytic before further processing; total number of cells is high, 20-30 million cells, but a large proportion of them are probably erythrocytes.The vitality of the cells is below 87% (study sponsor gives 90% as a minimum requirement).After freezing (with dmso, protocol dictated by study sponsor), the vitality is> 90% and the cell count is 7-8 million.Study sites centrifuge 17 min between 1650 rcf and 1800 rcf.
 
Event Description
It was reported that 30 bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml experienced hemolysis during use.The following information was provided by the initial reporter: cpt, isolated cells contaminated with erythrocytes and low vitality laboratory receives centrifuged cpt from participants of a clinical study; the cells collected above the gel are contaminated with erythrocytes, often the sample looks hemolytic before further processing; total number of cells is high, 20-30 million cells, but a large proportion of them are probably erythrocytes.The vitality of the cells is below 87% (study sponsor gives 90% as a minimum requirement).After freezing (with dmso, protocol dictated by study sponsor), the vitality is> 90% and the cell count is 7-8 million.Study sites centrifuge 17 min between 1650 rcf and 1800 rcf.
 
Manufacturer Narrative
H.6.Investigation: bd had not received samples, but photos were provided by the customer facility for investigation.The photos were evaluated and the customer's indicated failure mode for hemolysis with the incident lot was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Hemolysis can be caused by many sources, including certain patient pathological conditions, improper specimen collection, specimen processing, and specimen transport.Specimen collection factors that can contribute to hemolysis range from prolonged tourniquet time and improper venipuncture technique to transferring a sample from a syringe draw or iv catheter.Specimen processing factors include vigorous mixing or shaking of the specimen, not allowing the specimen to clot for the recommended amount of time, prolonged contact of serum or plasma with cells, and exposure to excessive heat or cold.Finally, mechanical trauma and other adverse conditions during transport of tubes can result in hemolysis.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
MDR Report Key9273518
MDR Text Key191174352
Report Number1917413-2019-02304
Device Sequence Number1
Product Code JCF
Combination Product (y/n)N
PMA/PMN Number
K891407
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 02/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/31/2019
Device Catalogue Number362780
Device Lot Number8059582
Initial Date Manufacturer Received 10/18/2019
Initial Date FDA Received11/04/2019
Supplement Dates Manufacturer Received10/18/2019
Supplement Dates FDA Received02/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-